Optiver Holding
IOVA icon

Optiver Holding’s Iovance Biotherapeutics IOVA Stock Holding History

Optiver Holding’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.2K Sell
17,608
-19,052
-52% -$72.4K ﹤0.01% 1091
2026
Q1 		$129K Buy
36,660
+7,092
+24% +$22.7K ﹤0.01% 869
2025
Q4 		$80.7K Buy
29,568
+28,625
+3,036% +$66.2K ﹤0.01% 837
2025
Q3 		$2.05K Buy
+943
New +$2.23K ﹤0.01% 2376
2024
Q3 		– Sell
-1,777
Closed -$14.3K – 1017
2024
Q2 		$14.3K Buy
+1,777
New +$19K ﹤0.01% 674

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Optiver Holding's IOVA Position: Q2 2026 in Review

Optiver Holding reduced its Iovance Biotherapeutics (IOVA) stake by 52% in Q2 2026, selling an estimated $72.4K and leaving 17,608 shares worth $73.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Optiver Holding first reported a position in IOVA in Q2 2024 and has held it in 5 quarters since. The position peaked at $129K in Q1 2026. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Optiver Holding held 17,608 shares of Iovance Biotherapeutics worth $73.2K as of Q2 2026.
  • Optiver Holding sold 19,052 Iovance Biotherapeutics shares in Q2 2026, an estimated $72.4K.
  • Iovance Biotherapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1091 holding.
  • Optiver Holding first reported a position in Iovance Biotherapeutics in Q2 2024 and has held it in 5 quarters since.
  • Optiver Holding's Iovance Biotherapeutics position peaked at $129K in Q1 2026.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.